PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Moreover, it has also recently been demonstrated that the PNPLA3 GG variant promotes the progression of MASLD by inducing mitochondrial dysfunction (Luukkonen et al., 2023; Gou et al., 2023; Martin-Fernandez et al., 2022).